<DOC>
	<DOC>NCT01106716</DOC>
	<brief_summary>The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postherpetic neuralgia pain</brief_summary>
	<brief_title>Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>diagnosis of PHN with pain for at least 3 months after segmental herpes zoster eruption pain score at least 4 on 11point numerical rating scale (010) stable doses of analgesic medications for at least 1 month" diagnosis of PHN with pain for at least 3 months after segmental herpes zoster eruption pain score at least 4 on 11point numerical rating scale (010) stable doses of analgesic medications for at least 1 month"</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Lidocaine</keyword>
	<keyword>Lignocaine</keyword>
	<keyword>Analgesics. Non-narcotic / therapeutic use</keyword>
	<keyword>Neuralgia, Postherpetic</keyword>
	<keyword>Pain</keyword>
	<keyword>Pain measurement / drug effect</keyword>
	<keyword>Pain postoperative / drug therapy</keyword>
	<keyword>PHN</keyword>
</DOC>